Virtus LifeSci Biotech Products ETF Rating → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free BBP Stock Alerts $56.52 -0.12 (-0.21%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.73Holdings in BBP have an aggregate rating of Moderate Buy based on 608 analyst ratings issued in the past year covering 50 companies (98.4% of the portfolio).BBP Aggregate Price Target$84.7549.96% UpsideHigh Prediction$126.77Average Prediction$84.75Low Prediction$60.35Holdings in BBP have an aggregate price target of $84.75 and a range of $60.35 to $126.77 covering 50 companies (98.4% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.47%ADMAADMA Biologics$9.55+0.7%2 of 5 stars3.25$10.50 9.9%4Positive News3.88%TARSTarsus Pharmaceuticals$32.96-5.1%2 of 5 stars2.88$50.38 52.8%8Positive News3.15%MRNAModerna$142.55-5.9%3 of 5 stars2.24$126.46 -11.3%17Insider Selling3.08%DCPHDeciphera Pharmaceuticals$25.54+0.0%3 of 5 stars2.30$24.17 -5.4%10Short Interest ↓Positive News2.79%PTCTPTC Therapeutics$36.36+1.5%3 of 5 stars2.07$35.67 -1.9%14Analyst Forecast2.74%AGIOAgios Pharmaceuticals$36.34-3.2%2 of 5 stars2.50$35.00 -3.7%4Analyst UpgradeShort Interest ↓Analyst Revision2.65%SRPTSarepta Therapeutics$129.86+4.3%5 of 5 stars2.80$164.00 26.3%15Analyst ForecastHigh Trading Volume2.61%LXRXLexicon Pharmaceuticals$1.702 of 5 stars2.67$5.00 194.1%3Positive News2.45%LGNDLigand Pharmaceuticals$85.05+1.3%5 of 5 stars3.00$116.33 36.8%3Positive News2.38%BPMCBlueprint Medicines$105.56-0.8%1 of 5 stars2.53$103.94 -1.5%17Positive News2.35%SWTXSpringWorks Therapeutics$41.46-2.7%1 of 5 stars3.00$68.83 66.0%6Analyst Forecast2.24%NBIXNeurocrine Biosciences$135.41-0.9%5 of 5 stars2.80$150.85 11.4%25Analyst ForecastInsider SellingHigh Trading Volume2.21%KNSAKiniksa Pharmaceuticals$19.01+2.4%2 of 5 stars3.00$31.00 63.1%4Positive NewsHigh Trading Volume2.19%HALOHalozyme Therapeutics$44.29+2.2%5 of 5 stars2.83$53.14 20.0%6Positive News2.19%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑2.16%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume2.10%VRTXVertex Pharmaceuticals$455.34+2.8%4 of 5 stars2.50$438.62 -3.7%24Analyst ForecastInsider SellingNews CoverageHigh Trading Volume2.07%UTHRUnited Therapeutics$275.13+1.7%5 of 5 stars2.90$309.44 12.5%10Insider SellingHigh Trading Volume2.03%AXSMAxsome Therapeutics$73.43-1.1%5 of 5 stars2.92$121.92 66.0%13Insider Selling1.96%ROIVRoivant Sciences$10.36-0.3%2 of 5 stars2.90$16.90 63.1%10Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.93%ASNDAscendis Pharma A/S$135.10-1.7%3 of 5 stars2.89$179.44 32.8%9Analyst ForecastShort Interest ↓1.92%ITCIIntra-Cellular Therapies$67.24+2.4%4 of 5 stars2.90$90.17 34.1%10Short Interest ↑1.83%BCRXBioCryst Pharmaceuticals$6.46-1.7%4 of 5 stars3.00$14.00 116.7%7Positive News1.78%BGNEBeiGene$148.85-3.5%3 of 5 stars2.80$251.93 69.3%10Short Interest ↓News CoveragePositive NewsGap Down1.74%RYTMRhythm Pharmaceuticals$35.68-2.7%3 of 5 stars2.83$54.33 52.3%61.73%RAREUltragenyx Pharmaceutical$40.14+3.9%5 of 5 stars2.93$90.67 125.9%14Analyst ForecastNews CoverageGap UpHigh Trading Volume1.73%BIIBBiogen$224.94+2.2%5 of 5 stars2.65$286.50 27.4%26Analyst ForecastShort Interest ↑News Coverage1.73%EXELExelixis$21.69+4.4%5 of 5 stars2.59$26.13 20.4%17Insider BuyingPositive NewsGap Up1.72%INCYIncyte$57.79+0.9%5 of 5 stars2.44$73.69 27.5%18Short Interest ↓Positive NewsHigh Trading Volume1.71%BNTXBioNTech$100.60+1.9%2 of 5 stars2.20$111.70 11.0%10Analyst ForecastShort Interest ↓1.70%INSMInsmed$55.05-3.4%3 of 5 stars3.00$56.38 2.4%16Analyst ForecastInsider SellingShort Interest ↑Analyst RevisionNews Coverage1.69%HRMYHarmony Biosciences$29.40+1.8%4 of 5 stars2.50$40.63 38.2%8Short Interest ↑1.69%CRSPCRISPR Therapeutics$53.74-0.6%2 of 5 stars2.31$73.46 36.7%16Short Interest ↑Analyst Revision1.59%APLSApellis Pharmaceuticals$39.25-3.7%4 of 5 stars2.81$74.38 89.5%16Analyst ForecastAnalyst Revision1.59%IMCRImmunocore$48.98+4.9%2 of 5 stars2.87$81.85 67.1%15Analyst Forecast1.59%GILDGilead Sciences$64.27+0.3%5 of 5 stars2.35$83.69 30.2%17News CoverageGap DownHigh Trading Volume1.58%BBIOBridgeBio Pharma$28.01-2.9%5 of 5 stars2.92$47.62 70.0%12Analyst ForecastAnalyst Revision1.58%TBPHTheravance Biopharma$8.62+1.5%2 of 5 stars3.00$20.50 137.8%2Analyst DowngradeAnalyst Revision1.54%ALNYAlnylam Pharmaceuticals$148.43-1.1%5 of 5 stars2.59$216.19 45.6%17Insider SellingHigh Trading Volume1.51%BMRNBioMarin Pharmaceutical$75.07+0.8%5 of 5 stars2.57$106.11 41.3%21Insider Selling1.50%FOLDAmicus Therapeutics$9.80-0.8%4 of 5 stars2.88$17.57 79.3%8Analyst ForecastAnalyst RevisionPositive News1.49%IONSIonis Pharmaceuticals$37.57+2.8%4 of 5 stars2.71$59.54 58.5%14Positive News1.42%LEGNLegend Biotech$40.01-7.7%3 of 5 stars3.00$81.10 102.7%11High Trading Volume1.40%MIRMMirum Pharmaceuticals$24.03-1.7%4 of 5 stars3.10$49.73 106.9%10Positive News1.37%TVTXTravere Therapeutics$7.42+5.7%1 of 5 stars2.62$15.58 110.0%13Positive News1.32%ZLABZai Lab$17.78-2.3%3 of 5 stars3.00$64.22 261.2%5Short Interest ↓Gap DownHigh Trading Volume1.23%AUPHAurinia Pharmaceuticals$5.42+0.7%2 of 5 stars2.75$10.00 84.5%4Short Interest ↑1.07%IRWDIronwood Pharmaceuticals$6.30+4.0%4 of 5 stars3.00$18.40 192.1%5Short Interest ↑News Coverage1.03%ACADACADIA Pharmaceuticals$15.10+0.7%4 of 5 stars2.75$28.94 91.6%16Analyst Revision1.01%SAGESage Therapeutics$11.11-3.4%4 of 5 stars2.05$35.05 215.5%20Analyst UpgradeNews Coverage This page (NYSEARCA:BBP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
